UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 25, 2013
Proto Labs, Inc.
(Exact name of registrant as specified in its charter)
Minnesota | 001-35435 | 41-1939628 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification Number) |
5540 Pioneer Creek Drive Maple Plain, Minnesota |
55359 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (763) 479-3680
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition
On April 25, 2013, Proto Labs, Inc. issued a press release announcing its first quarter 2013 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 | Press release of Proto Labs, Inc. dated April 25, 2013, announcing its first quarter 2013 financial results |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Proto Labs, Inc. | ||||||
Date: April 25, 2013 | By: | /s/ John R. Judd | ||||
John R. Judd | ||||||
Chief Financial Officer |
EXHIBIT INDEX
Exhibit Number |
Description |
Manner of Filing | ||
99.1 | Press release of Proto Labs, Inc. dated April 25, 2013, announcing its first quarter 2013 financial results. | Filed electronically |
Exhibit 99.1
Proto Labs Reports Record Revenue and Net Income for the First Quarter 2013
Quarterly Revenue Increases 25% Year over Year to $37.3 Million
Quarterly Net Income Increases 73% Year over Year to $8.3 Million
MAPLE PLAIN, Minn.April 25, 2013 Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled quick-turn manufacturer, today announced its financial results for the first quarter ended March 31, 2013.
Highlights include:
| Revenue for the first quarter of 2013 increased to a record $37.3 million, 25 percent above revenue of $30.0 million in the first quarter of 2012. |
| During the quarter, revenue from 710 new customer companies totaled $3.1 million and revenue from 3,528 existing customer companies totaled $34.2 million. |
| Net income for the first quarter of 2013 increased to a record $8.3 million, or $0.32 per diluted share. Non-GAAP net income, excluding the after tax expense of stock compensation, was $8.9 million, or $0.35 per diluted share. See Non-GAAP Financial Measure below. |
We are pleased to report that our United States, European and Japanese operations each achieved record quarterly revenues for the first quarter of 2013, a consistent theme for our teams. Our marketing and sales strategies combined with efficient operations continue to make us a very fast growing and highly profitable company, said Proto Labs President and CEO Brad Cleveland.
Additional highlights include:
| Gross margin was 62.4 percent of revenue in the first quarter of 2013 compared with 59.1 percent during the same quarter in 2012. |
| During the first quarter of 2013, spending on research and development, including the Protoworks initiatives, totaled $2.6 million, or 7.0 percent of revenue. This compares to $1.7 million, or 5.5 percent of revenue during the first quarter of 2012. |
| Operating margin was 30.5 percent of revenue during the first quarter of 2013 compared to 25.5 percent in the first quarter of 2012. |
| Cash generated from operations totaled $11.1 million during the first quarter of 2013. Expenditures on capital equipment were $2.5 million during the quarter. |
As we have discussed in the past, one of our ongoing challenges is building awareness among the millions of global product developers. Our first quarter results demonstrate the success of our worldwide marketing and sales teams, and we believe these efforts will continue to drive revenue as we move ahead, concluded Mr. Cleveland.
Non-GAAP Financial Measure
The company has included non-GAAP net income, adjusted for stock-based compensation expense in this press release to provide investors with additional information regarding the companys financial results. The company has provided below a reconciliation of non-GAAP net income, adjusted for stock-based compensation expense, to net income, the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP net income, adjusted for stock-based compensation expense, is used by the companys management and board of directors to understand and evaluate operating performance and trends and provides a useful measure for period-to-period comparisons of the companys business. Accordingly, the company believes that non-GAAP net income, adjusted for stock-based compensation expense, provides useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.
Conference Call
The company has scheduled a conference call to discuss its first quarter financial results today, April 25 at 8:30 a.m. ET. To access the call in the U.S. please dial 866-700-0133. Outside the U.S. please dial 617-213-8831. Use participant code 60036824#. A simultaneous webcast of the call will also be available on the investor relations section of the companys website at www.protolabs.com/investors. An audio replay will be available for 14 days following the call on the investor relations website of Proto Labs website.
About Proto Labs, Inc.
Proto Labs is a leading online and technology-enabled quick-turn manufacturer of custom parts for prototyping and short-run production. Proto Labs provides Real Parts, Really Fast to product developers worldwide. Proto Labs utilizes computer numerical control (CNC) machining and injection molding to manufacture custom parts for our customers. For more information, visit protolabs.com.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Proto Labs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the Risk Factors section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Proto Labs future results. The forward-looking statements included in this press release are made only as of the date hereof. Proto Labs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Proto Labs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
Contacts:
Investor Relations:
Jack Judd, 763-479-7408
jack.judd@protolabs.com
Media Relations:
Bill Dietrick, 763-479-7664
bill.dietrick@protolabs.com
Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
March 31, | December 31, | |||||||
2013 | 2012 | |||||||
(Unaudited) | ||||||||
Assets |
||||||||
Current assets |
||||||||
Cash and cash equivalents |
$ | 27,929 | $ | 36,759 | ||||
Short-term marketable securities |
35,695 | 25,137 | ||||||
Accounts receivable, net |
17,468 | 15,791 | ||||||
Inventory |
4,717 | 4,619 | ||||||
Other current assets |
8,423 | 7,850 | ||||||
|
|
|
|
|||||
Total current assets |
94,232 | 90,156 | ||||||
Property and equipment, net |
45,629 | 45,316 | ||||||
Long-term marketable securities |
48,877 | 36,965 | ||||||
Other long-term assets |
262 | 285 | ||||||
|
|
|
|
|||||
Total assets |
$ | 189,000 | $ | 172,722 | ||||
|
|
|
|
|||||
Liabilities and shareholders equity |
||||||||
Current liabilities |
||||||||
Accounts payable |
$ | 5,759 | $ | 4,758 | ||||
Accrued compensation |
7,468 | 5,995 | ||||||
Accrued liabilities and other |
574 | 513 | ||||||
Current portion of long-term debt obligations |
209 | 273 | ||||||
|
|
|
|
|||||
Total current liabilities |
14,010 | 11,539 | ||||||
Deferred tax liability |
3,346 | 3,346 | ||||||
Long-term debt obligations |
287 | 356 | ||||||
Other |
728 | 782 | ||||||
Shareholders equity |
170,629 | 156,699 | ||||||
|
|
|
|
|||||
Total liabilities and shareholders equity |
$ | 189,000 | $ | 172,722 | ||||
|
|
|
|
Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended | ||||||||
March 31, | ||||||||
2013 | 2012 | |||||||
Revenues |
||||||||
Protomold |
$ | 26,880 | $ | 21,793 | ||||
Firstcut |
10,433 | 8,177 | ||||||
|
|
|
|
|||||
Total revenues |
37,313 | 29,970 | ||||||
Cost of revenues |
14,034 | 12,243 | ||||||
|
|
|
|
|||||
Gross profit |
23,279 | 17,727 | ||||||
Operating expenses |
||||||||
Marketing and sales |
5,263 | 4,441 | ||||||
Research and development |
2,628 | 1,660 | ||||||
General and administrative |
3,994 | 3,988 | ||||||
|
|
|
|
|||||
Total operating expenses |
11,885 | 10,089 | ||||||
|
|
|
|
|||||
Income from operations |
11,394 | 7,638 | ||||||
Other income (expense), net |
3 | (577 | ) | |||||
|
|
|
|
|||||
Income before income taxes |
11,397 | 7,061 | ||||||
Provision for income taxes |
3,110 | 2,279 | ||||||
|
|
|
|
|||||
Net income |
$ | 8,287 | $ | 4,782 | ||||
|
|
|
|
|||||
Net income per share: |
||||||||
Basic |
$ | 0.33 | $ | 0.23 | ||||
|
|
|
|
|||||
Diluted |
$ | 0.32 | $ | 0.22 | ||||
|
|
|
|
|||||
Shares used to compute net income per share: |
||||||||
Basic |
25,014,907 | 20,934,948 | ||||||
Diluted |
25,645,744 | 22,226,356 |
Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
Three Months Ended | ||||||||
March 31, | ||||||||
2013 | 2012 | |||||||
Operating activities |
||||||||
Net income |
$ | 8,287 | $ | 4,782 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
1,734 | 1,328 | ||||||
Stock-based compensation expense |
865 | 850 | ||||||
Deferred taxes |
148 | | ||||||
Excess tax benefit from stock-based compensation |
(4,067 | ) | | |||||
Amortization of held-to-maturity securities |
304 | | ||||||
Changes in operating assets and liabilities: |
3,874 | 451 | ||||||
|
|
|
|
|||||
Net cash provided by operating activities |
11,145 | 7,411 | ||||||
|
|
|
|
|||||
Investing activities |
||||||||
Purchases of property and equipment |
(2,548 | ) | (8,264 | ) | ||||
Purchases of marketable securities |
(41,088 | ) | | |||||
Proceeds from sale of marketable securities |
18,313 | 250 | ||||||
|
|
|
|
|||||
Net cash used in investing activities |
(25,323 | ) | (8,014 | ) | ||||
|
|
|
|
|||||
Financing activities |
||||||||
Proceeds from initial public offering, net of offering costs |
| 71,675 | ||||||
Payments on debt |
(92 | ) | (94 | ) | ||||
Proceeds from exercises of warrants and stock options |
1,619 | 30 | ||||||
Excess tax benefit from stock-based compensation |
4,067 | | ||||||
|
|
|
|
|||||
Net cash provided by financing activities |
5,594 | 71,611 | ||||||
|
|
|
|
|||||
Effect of exchange rate changes on cash and cash equivalents |
(246 | ) | 536 | |||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents |
(8,830 | ) | 71,544 | |||||
Cash and cash equivalents, beginning of period |
36,759 | 8,135 | ||||||
|
|
|
|
|||||
Cash and cash equivalents, end of period |
$ | 27,929 | $ | 79,679 | ||||
|
|
|
|
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Financial Measure
(In thousands, except share and per share amounts)
(Unaudited)
Three Months Ended | ||||
March 31, 2013 | ||||
Non-GAAP net income, adjusted for stock-based compensation expense: |
||||
GAAP net income |
$ | 8,287 | ||
Add back: Stock-based compensation expense |
||||
Cost of revenue |
71 | |||
Marketing and sales |
150 | |||
Research and development |
173 | |||
General and administrative |
471 | |||
|
|
|||
Total stock-based compensation expense |
865 | |||
Less: Tax benefit on stock-based compensation |
(206 | ) | ||
|
|
|||
Non-GAAP net income |
$ | 8,946 | ||
|
|
|||
Non-GAAP net income per share: |
||||
Basic |
$ | 0.36 | ||
|
|
|||
Diluted |
$ | 0.35 | ||
|
|
|||
Shares used to compute non-GAAP net income per share: |
||||
Basic |
25,014,907 | |||
Diluted |
25,645,744 |
Proto Labs, Inc.
Revenue by GeographyBased on Shipping Location
(In thousands)
(Unaudited)
Three Months Ended | ||||||||
March 31, | ||||||||
2013 | 2012 | |||||||
Revenues |
||||||||
Domestic |
||||||||
United States |
$ | 28,148 | $ | 22,175 | ||||
International |
||||||||
Europe |
6,465 | 5,480 | ||||||
Japan |
1,349 | 1,358 | ||||||
United States |
1,351 | 957 | ||||||
|
|
|
|
|||||
Total international |
9,165 | 7,795 | ||||||
|
|
|
|
|||||
Total revenue |
$ | 37,313 | $ | 29,970 | ||||
|
|
|
|
Proto Labs, Inc.
Customer Information
(In thousands, except customer amounts)
(Unaudited)
Three Months Ended March 31, | ||||||||||||||||
2013 | 2012 | |||||||||||||||
Number of Customers |
Revenue ($) | Number of Customers |
Revenue ($) | |||||||||||||
New Customers |
710 | $ | 3,078 | 753 | $ | 2,920 | ||||||||||
Existing Customers |
3,528 | 34,235 | 2,931 | 27,050 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total |
4,238 | $ | 37,313 | 3,684 | $ | 29,970 | ||||||||||
|
|
|
|
|
|
|
|